Structural heart devices are transforming the treatment of complex cardiovascular diseases by offering minimally invasive alternatives to conventional open-heart surgeries. These devices are widely used to treat conditions such as aortic stenosis, mitral valve disorders, septal defects, and other structural abnormalities of the heart. The increasing burden of cardiovascular diseases (CVDs), coupled with rapid technological advancements in transcatheter therapies, is significantly boosting market expansion across developed and emerging economies.

The global Structural Heart Devices Market was valued at USD 18.6 billion in 2025 and is projected to grow from USD 21.1 billion in 2026 to USD 51.0 billion by 2033, registering a CAGR of 13.5% during the forecast period. Growing preference for minimally invasive cardiac interventions, an aging population, increasing prevalence of valvular heart diseases, and continuous innovation by leading medical device manufacturers are expected to fuel long-term market growth.

Key Highlights

• Market Size (2025): USD 18.6 Billion
• Projected Market Size (2033): USD 51.0 Billion
• CAGR (2026–2033): 13.5%
• Largest Regional Market: North America (52.5% revenue share in 2025)
• Fastest-Growing Regional Market: Asia Pacific
• By Type: TAVR (Transcatheter Aortic Valve Replacement) (53.4% revenue share in 2025)

Structural Heart Devices Market Overview

The growing prevalence of cardiovascular diseases worldwide is creating significant demand for advanced structural heart devices. Rising cases of aortic stenosis, congenital heart defects, mitral valve diseases, and heart failure have encouraged healthcare providers to adopt minimally invasive treatment options that improve patient outcomes while reducing hospitalization time and surgical complications.

Technological advancements continue to reshape the industry as manufacturers introduce next-generation transcatheter valves, improved delivery systems, and innovative repair technologies. Increasing regulatory approvals, expanding clinical evidence supporting minimally invasive procedures, and favorable reimbursement policies are further strengthening market growth. In addition, hospitals are increasingly investing in advanced cardiac care infrastructure to improve treatment accessibility and procedural efficiency.

Download a Free Sample Copy

Want detailed market forecasts, company profiles, regional analysis, and competitive intelligence?

Download a free sample copy of the Structural Heart Devices Market report to explore comprehensive market insights, future opportunities, and industry trends.

Key Market Trends

One of the most significant trends influencing the structural heart devices market is the rapid adoption of Transcatheter Aortic Valve Replacement (TAVR) procedures. Physicians increasingly prefer TAVR because it provides faster recovery, lower procedural risk, and excellent long-term clinical outcomes compared to conventional surgical approaches.

The market is also witnessing continuous product innovation. Companies are introducing advanced valve systems with improved coronary access, enhanced durability, simplified implantation techniques, and superior procedural performance. These technological improvements are expanding treatment eligibility to younger patients and supporting wider clinical adoption across global healthcare systems.

Market Segments & Key Drivers

By Type

The TAVR (Transcatheter Aortic Valve Replacement) segment dominated the global market in 2025, accounting for 53.4% of total revenue. Increasing preference for minimally invasive cardiac procedures, rising incidence of severe aortic stenosis, and growing clinical acceptance of catheter-based valve replacement continue to drive segment growth. Continuous innovation by major manufacturers and expanding regulatory approvals are expected to further strengthen TAVR adoption throughout the forecast period.

The SAVR (Surgical Aortic Valve Replacement) segment is also expected to witness steady growth, supported by technological advancements in surgical heart valves and increasing demand for durable valve replacement solutions among specific patient populations.

Looking for more specific insights? Customize this report to suite your business needs

Regional Insights

North America

North America dominated the global structural heart devices market, accounting for 52.5% of total revenue in 2025. The region's leadership is driven by the high prevalence of cardiovascular diseases, increasing adoption of minimally invasive cardiac procedures, favorable reimbursement policies, and strong healthcare infrastructure. Growing awareness campaigns and government initiatives are further supporting market expansion. For instance, the American Heart Association received USD 8.4 million in CDC funding to launch national heart valve disease awareness campaigns.

Asia Pacific

Asia Pacific is projected to register the fastest CAGR during the forecast period (2026–2033). Rising healthcare investments, increasing elderly populations, improving access to advanced cardiac care, and growing awareness regarding structural heart diseases are driving demand across countries such as China, India, and Japan.

Europe

Europe is expected to witness significant growth owing to the increasing burden of cardiovascular diseases and continuous technological innovations in transcatheter valve therapies. The region is also benefiting from favorable regulatory approvals and expanding adoption of advanced structural heart interventions. Countries including Italy are experiencing growing demand for valve replacement procedures due to the rising incidence of cardiovascular disorders.

Latin America

The Latin American market is gradually expanding as healthcare providers increasingly adopt minimally invasive cardiac procedures. Countries such as Brazil and Argentina are investing in cardiovascular care infrastructure, while rising awareness and improving healthcare accessibility continue to support regional growth.

Middle East & Africa

The Middle East & Africa market is gaining momentum due to improving healthcare infrastructure, increasing investments in specialized cardiac care centers, and rising medical tourism. Countries such as Saudi Arabia and the UAE are accelerating the adoption of next-generation structural heart technologies to address the growing burden of cardiovascular diseases.

Explore Grand View Horizon to see global and regional level statistics related to the Structural Heart Devices Market

Major Industry Players

The structural heart devices market is highly competitive, with leading companies focusing on product innovation, regulatory approvals, mergers & acquisitions, strategic partnerships, and geographic expansion to strengthen their market positions. Manufacturers are continuously investing in research and development to introduce advanced transcatheter heart valves, mitral repair systems, and septal closure devices that improve clinical outcomes while reducing procedural risks.

Key companies operating in the global structural heart devices market include:

• Boston Scientific Corporation
• Medtronic plc
• Edwards Lifesciences Corporation
• Abbott Laboratories
• ST. JUDE MEDICAL
• Biomerics
• Comed BV
• LivaNova PLC
• JenaValve Technology, Inc.
• CardioKinetix

Explore our dedicated business services:

• Brainshare Consulting – End-to-end business consulting services including Opportunity assessment, GTM support, Competitive intelligence, and Consumer Analytics.
• Custom Research – Get a market intelligence report tailored to your specific requirements and aligned with your business goals.
• Consumer Insights – Capture real, evolving consumer sentiment and behavior to help you make data driven strategies.
• Horizon Databooks – Access the world’s largest portal of Market Reports & Statistics
• Investment Insights – Make investment decisions with data driven insights, powered by domain and technology
• Signal (Pricing Intelligence) - Commodity price intelligence to drives strategic advantage.

About us:
Grand View Research, a market research and consulting company, provides syndicated research reports, customized research reports, and consulting services. Grand View Research database is used by the world's renowned academic institutions and Fortune 500 companies to understand the global and regional business environment. Our database features thousands of statistics and in-depth analysis on 46 industries in 25 major countries worldwide.